Reviewed October 2013
What is restless legs syndrome?
Restless legs syndrome is a neurological condition that causes an irresistible urge to move the legs. The movement is triggered by strange or uncomfortable feelings, often described as crawling, pulling, or itching, deep within both legs. The feelings usually occur while the affected person is sitting or lying down and are worse at night. Movement, such as kicking, stretching, rubbing, or pacing, make the discomfort go away, at least temporarily. The unpleasant feelings and the resulting need to move the legs often make it difficult for an affected person to fall asleep or stay asleep.
The signs and symptoms of restless legs syndrome range from mild to severe; people with mild cases may experience symptoms a few times a month, while those with more severe cases may have symptoms every night. In severe cases, the uncomfortable feelings can affect the arms or other parts of the body in addition to the legs.
Many people with restless legs syndrome also experience uncontrollable, repetitive leg movements that occur while they are sleeping or while relaxed or drowsy. When these movements occur during sleep, they are called periodic limb movements of sleep (PLMS); when they occur while a person is awake, they are called periodic limb movements of wakefulness (PLMW). It is unclear whether PLMS and PLMW are features of restless legs syndrome itself or represent similar, but separate, conditions.
Restless legs syndrome and PLMS can affect the quality and amount of sleep. As a result of these conditions, affected individuals may have difficulty concentrating during the day, and some develop mood swings, depression, or other health problems.
Researchers have described early-onset and late-onset forms of restless legs syndrome. The early-onset form begins before age 45, and sometimes as early as childhood. The signs and symptoms of this form usually worsen slowly with time. The late-onset form begins after age 45, and its signs and symptoms tend to worsen more rapidly.
How common is restless legs syndrome?
Restless legs syndrome is one of the most common sleep and movement disorders. It affects an estimated 5 to 10 percent of adults and 2 to 4 percent of children in the United States. For unknown reasons, the disorder affects women more often than men. The prevalence of restless legs syndrome increases with age.
What genes are related to restless legs syndrome?
Restless legs syndrome likely results from a combination of genetic and environmental factors, many of which are unknown.
Studies suggest that restless legs syndrome is related to a shortage (deficiency) of iron in certain parts of the brain. Iron is involved in several critical activities in brain cells, including the production of a chemical messenger (neurotransmitter) called dopamine. Among its many functions, dopamine triggers signals within the nervous system that help the brain control physical movement. Researchers believe that malfunction of the dopamine signaling system may underlie the abnormal movements in people with restless legs syndrome. However, it is unclear how iron deficiency is related to abnormal dopamine signaling, or how these changes in the brain lead to the particular signs and symptoms of the condition.
Variations in several genes have been studied as risk factors for restless legs syndrome. Most of these genes are thought to be involved in the development of nerve cells (neurons) before birth. It is unclear whether any of the genes play roles in brain iron levels or in dopamine signaling. Variations in known genes appear to account for only a small percentage of the risk of developing restless legs syndrome. Changes in other genes, which have not been identified, probably also contribute to this complex disorder. Researchers suspect that the early-onset form of restless legs syndrome is more likely than the late-onset form to have a genetic basis.
Nongenetic factors are also thought to play a role in restless legs syndrome. For example, several other disorders increase the risk of developing the condition. These include a life-threatening failure of kidney function called end-stage renal disease, diabetes mellitus, multiple sclerosis, rheumatoid arthritis, and Parkinson disease. People with low iron levels associated with a shortage of red blood cells (anemia) and women who are pregnant are also more likely to develop restless legs syndrome. In these cases, the condition usually improves or goes away when iron levels increase or after the woman gives birth.
Restless legs syndrome can be triggered by medications, including certain drugs used to treat nausea, depression and other mental health disorders, colds and allergies, heart problems, and high blood pressure. Use of caffeine, nicotine, or alcohol can also trigger restless legs syndrome or make the signs and symptoms worse. In these cases, the condition usually improves or goes away once a person stops using these medications or substances.
Changes in these genes are associated with restless legs syndrome.
How do people inherit restless legs syndrome?
The inheritance pattern of restless legs syndrome is usually unclear because many genetic and environmental factors can be involved. The disorder often runs in families: 40 to 90 percent of affected individuals report having at least one affected first-degree relative, such as a parent or sibling, and many families have multiple affected family members. Studies suggest that the early-onset form of the disorder is more likely to run in families than the late-onset form.
In some affected families, restless legs syndrome appears to have an autosomal dominant pattern of inheritance. Autosomal dominant inheritance suggests that one copy of an altered gene in each cell is sufficient to cause the disorder. However, the genetic changes associated with restless legs syndrome in these families have not been identified.
Where can I find information about diagnosis or management of restless legs syndrome?
These resources address the diagnosis or management of restless legs syndrome and may include treatment providers.
- Agency for Healthcare Research and Quality: Options for Treating Restless Legs Syndrome (http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1673)
- National Heart, Lung, and Blood Institute: How is Restless Legs Syndrome Diagnosed? (http://www.nhlbi.nih.gov/health/health-topics/topics/rls/diagnosis)
- National Heart, Lung, and Blood Institute: How is Restless Legs Syndrome Treated? (http://www.nhlbi.nih.gov/health/health-topics/topics/rls/treatment)
- Willis-Ekbom Disease Foundation: Diagnosis (http://www.rls.org/about-rls-wed/diagnosis)
- Willis-Ekbom Disease Foundation: Treatment Options (http://www.rls.org/about-rls-wed/treatment-options)
You might also find information on the diagnosis or management of restless legs syndrome in
Educational resources (/condition/restless-legs-syndrome/show/Educational+resources) and Patient support (/condition/restless-legs-syndrome/show/Patient+support).
General information about the diagnosis (http://ghr.nlm.nih.gov/handbook/consult/diagnosis) and management (http://ghr.nlm.nih.gov/handbook/consult/treatment) of genetic conditions is available in the Handbook.
To locate a healthcare provider, see How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.
Where can I find additional information about restless legs syndrome?
You may find the following resources about restless legs syndrome helpful. These materials are written for the general public.
MedlinePlus - Health information
- Encyclopedia: Restless Leg Syndrome (http://www.nlm.nih.gov/medlineplus/ency/article/000807.htm)
- Health Topic: Restless Legs (http://www.nlm.nih.gov/medlineplus/restlesslegs.html)
Additional NIH Resources - National Institutes of Health
- National Heart, Lung, and Blood Institute (http://www.nhlbi.nih.gov/health/health-topics/topics/rls/)
- National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/disorders/restless_legs/restless_legs.htm)
Educational resources - Information pages
- Cleveland Clinic (http://my.clevelandclinic.org/services/neurological_institute/sleep-disorders-center/disorders-conditions/hic-restless-legs-syndrome)
- Disease InfoSearch: Restless legs syndrome, susceptibility to, 1 (http://www.diseaseinfosearch.org/Restless+legs+syndrome%2C+susceptibility+to%2C+1/6229)
- Disease InfoSearch: Restless legs syndrome, susceptibility to, 2 (http://www.diseaseinfosearch.org/Restless+legs+syndrome%2C+susceptibility+to%2C+2/6230)
- Disease InfoSearch: Restless legs syndrome, susceptibility to, 3 (http://www.diseaseinfosearch.org/Restless+legs+syndrome%2C+susceptibility+to%2C+3/6231)
- Disease InfoSearch: Restless legs syndrome, susceptibility to, 4 (http://www.diseaseinfosearch.org/Restless+legs+syndrome%2C+susceptibility+to%2C+4/6232)
- Disease InfoSearch: Restless legs syndrome, susceptibility to, 5 (http://www.diseaseinfosearch.org/Restless+legs+syndrome%2C+susceptibility+to%2C+5/6233)
- Disease InfoSearch: Restless legs syndrome, susceptibility to, 6 (http://www.diseaseinfosearch.org/Restless+legs+syndrome%2C+susceptibility+to%2C+6/6234)
- International Restless Legs Syndrome Study Group (http://irlssg.org/rls-facts/)
- Johns Hopkins Medicine (http://www.hopkinsmedicine.org/neurology_neurosurgery/centers_clinics/restless-legs-syndrome/what-is-rls/)
- Merck Manual Home Health Handbook for Patients & Caregivers (http://www.merckmanuals.com/home/brain_spinal_cord_and_nerve_disorders/sleep_disorders/periodic_limb_movement_disorder_and_restless_legs_syndrome.html)
Patient support - For patients and families
- European Alliance for Restless Legs Syndrome (http://www.earls.eu/)
- National Organization for Rare Disorders (NORD) (https://www.rarediseases.org/rare-disease-information/rare-diseases/byID/288/viewAbstract)
- Willis-Ekbom Disease Foundation (http://www.rls.org/)
You may also be interested in these resources, which are designed for healthcare professionals and researchers.
Genetic Testing Registry - Repository of genetic test information
- Genetic Testing Registry: Restless legs syndrome, susceptibility to, 1 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1876177)
- Genetic Testing Registry: Restless legs syndrome, susceptibility to, 2 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1837285)
- Genetic Testing Registry: Restless legs syndrome, susceptibility to, 3 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1864875)
- Genetic Testing Registry: Restless legs syndrome, susceptibility to, 4 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1864874)
- Genetic Testing Registry: Restless legs syndrome, susceptibility to, 5 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1970010)
- Genetic Testing Registry: Restless legs syndrome, susceptibility to, 6 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1970020)
- Genetic Testing Registry: Restless legs syndrome, susceptibility to, 8 (http://www.ncbi.nlm.nih.gov/gtr/conditions/CN169279)
- Genetic Testing Registry: Restless legs syndrome 7 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C2748506)
- ClinicalTrials.gov - Linking patients to medical research (https://clinicaltrials.gov/ct2/results?cond=%22restless%20legs%20syndrome%22)
- PubMed - Recent literature (http://www.ncbi.nlm.nih.gov/pubmed?term=%28Restless%20Legs%20Syndrome%5BMAJR%5D%29%20AND%20%28%28restless%20legs%20syndrome%5BTI%5D%29%20AND%20%28genetic*%5BTIAB%5D%29%29%20AND%20english%5Bla%5D%20AND%20human%5Bmh%5D%20AND%20%22last%201800%20days%22%5Bdp%5D)
OMIM - Genetic disorder catalog
- RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1 (http://omim.org/entry/102300)
- RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2 (http://omim.org/entry/608831)
- RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3 (http://omim.org/entry/610438)
- RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4 (http://omim.org/entry/610439)
- RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5 (http://omim.org/entry/611242)
- RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6 (http://omim.org/entry/611185)
- RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7 (http://omim.org/entry/612853)
- RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 8 (http://omim.org/entry/615197)
What other names do people use for restless legs syndrome?
- Ekbom's syndrome
- Ekbom syndrome
- restless leg syndrome
- Willis-Ekbom disease
- Willis-Ekbom disease
For more information about naming genetic conditions, see the Genetics Home Reference
Condition Naming Guidelines (http://ghr.nlm.nih.gov/ConditionNameGuide)
How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.
What if I still have specific questions about restless legs syndrome?
Ask the Genetic and Rare Diseases Information Center (http://rarediseases.info.nih.gov/gard).
What glossary definitions help with understanding restless legs syndrome?
autosomal dominant ;
diabetes mellitus ;
end-stage renal disease ;
first-degree relative ;
inheritance pattern ;
nervous system ;
pattern of inheritance ;
renal disease ;
risk factors ;
You may find definitions for these and many other terms in the Genetics Home Reference
- Dauvilliers Y, Winkelmann J. Restless legs syndrome: update on pathogenesis. Curr Opin Pulm Med. 2013 Nov;19(6):594-600. doi: 10.1097/MCP.0b013e328365ab07. Review. (http://www.ncbi.nlm.nih.gov/pubmed/24048084?dopt=Abstract)
- Schormair B, Kemlink D, Roeske D, Eckstein G, Xiong L, Lichtner P, Ripke S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Högl B, Frauscher B, Gschliesser V, Poewe W, Peglau I, Vodicka P, Vávrová J, Sonka K, Nevsimalova S, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichmann HE, Holsboer F, Müller-Myhsok B, Meitinger T, Winkelmann J. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet. 2008 Aug;40(8):946-8. doi: 10.1038/ng.190. Epub 2008 Jul 27. (http://www.ncbi.nlm.nih.gov/pubmed/18660810?dopt=Abstract)
- Trenkwalder C, Högl B, Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol. 2009 Apr;256(4):539-53. doi: 10.1007/s00415-009-0134-9. Epub 2009 Apr 27. (http://www.ncbi.nlm.nih.gov/pubmed/19444530?dopt=Abstract)
- Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010 Jun;6(6):337-46. doi: 10.1038/nrneurol.2010.55. Review. (http://www.ncbi.nlm.nih.gov/pubmed/20531433?dopt=Abstract)
- Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, Trenkwalder C, Dauvilliers Y, Polo O, Högl B, Berger K, Fuhs A, Gross N, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Xiong L, Montplaisir J, Rouleau GA, Fietze I, Vávrová J, Kemlink D, Sonka K, Nevsimalova S, Lin SC, Wszolek Z, Vilariño-Güell C, Farrer MJ, Gschliesser V, Frauscher B, Falkenstetter T, Poewe W, Allen RP, Earley CJ, Ondo WG, Le WD, Spieler D, Kaffe M, Zimprich A, Kettunen J, Perola M, Silander K, Cournu-Rebeix I, Francavilla M, Fontenille C, Fontaine B, Vodicka P, Prokisch H, Lichtner P, Peppard P, Faraco J, Mignot E, Gieger C, Illig T, Wichmann HE, Müller-Myhsok B, Meitinger T. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet. 2011 Jul;7(7):e1002171. doi: 10.1371/journal.pgen.1002171. Epub 2011 Jul 14. Erratum in: PLoS Genet. 2011 Aug;7(8). doi: 10.1371/annotation/393ad2d3-df4f-4770-87bc-00bfabf79362. (http://www.ncbi.nlm.nih.gov/pubmed/21779176?dopt=Abstract)
- Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, Fulda S, Pütz B, Eckstein G, Hauk S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Peglau I, Eisensehr I, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichmann HE, Holsboer F, Müller-Myhsok B, Meitinger T. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007 Aug;39(8):1000-6. Epub 2007 Jul 18. (http://www.ncbi.nlm.nih.gov/pubmed/17637780?dopt=Abstract)
- Winkelmann J, Wetter TC, Collado-Seidel V, Gasser T, Dichgans M, Yassouridis A, Trenkwalder C. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000 Aug 1;23(5):597-602. (http://www.ncbi.nlm.nih.gov/pubmed/10947027?dopt=Abstract)
- Xiong L, Montplaisir J, Desautels A, Barhdadi A, Turecki G, Levchenko A, Thibodeau P, Dubé MP, Gaspar C, Rouleau GA. Family study of restless legs syndrome in Quebec, Canada: clinical characterization of 671 familial cases. Arch Neurol. 2010 May;67(5):617-22. doi: 10.1001/archneurol.2010.67. (http://www.ncbi.nlm.nih.gov/pubmed/20457962?dopt=Abstract)
- Yang Q, Li L, Chen Q, Foldvary-Schaefer N, Ondo WG, Wang QK. Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population. Sleep Med. 2011 Sep;12(8):800-4. doi: 10.1016/j.sleep.2011.06.006. (http://www.ncbi.nlm.nih.gov/pubmed/21925394?dopt=Abstract)
The resources on this site should not be used as a substitute for
professional medical care or advice. Users seeking information about
a personal genetic disease, syndrome, or condition should consult with a qualified
See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.